
Alert: New Earnings Report (11/26/24)-Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR).
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) has reported E.P.S. of $-1.37 for its fourth fiscal quarter (ending September 30) versus $-1.02 for the same period a year ago — an increase of 34%. E.P.S. were $-5.00 […]